DE3486160T3 - Modifizierte lebende Pseudo-Rabies-Viren, diese enthaltende Impfstoffe gegen Pseudo-Rabies, Verfahren zur Herstellung und Verfahren zur Verwendung derselben. - Google Patents

Modifizierte lebende Pseudo-Rabies-Viren, diese enthaltende Impfstoffe gegen Pseudo-Rabies, Verfahren zur Herstellung und Verfahren zur Verwendung derselben.

Info

Publication number
DE3486160T3
DE3486160T3 DE19843486160 DE3486160T DE3486160T3 DE 3486160 T3 DE3486160 T3 DE 3486160T3 DE 19843486160 DE19843486160 DE 19843486160 DE 3486160 T DE3486160 T DE 3486160T DE 3486160 T3 DE3486160 T3 DE 3486160T3
Authority
DE
Germany
Prior art keywords
methods
pseudo rabies
making
vaccines against
modified live
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE19843486160
Other languages
English (en)
Other versions
DE3486160D1 (de
DE3486160T2 (de
Inventor
Malon Kit
Saul Kit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Novagene Ltd
Original Assignee
Baylor College of Medicine
Novagene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24265400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3486160(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baylor College of Medicine, Novagene Ltd filed Critical Baylor College of Medicine
Publication of DE3486160D1 publication Critical patent/DE3486160D1/de
Publication of DE3486160T2 publication Critical patent/DE3486160T2/de
Application granted granted Critical
Publication of DE3486160T3 publication Critical patent/DE3486160T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/822—Drug, bio-affecting and body treating compositions involving tk- virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19843486160 1983-12-30 1984-11-07 Modifizierte lebende Pseudo-Rabies-Viren, diese enthaltende Impfstoffe gegen Pseudo-Rabies, Verfahren zur Herstellung und Verfahren zur Verwendung derselben. Expired - Fee Related DE3486160T3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06567018 US4514497B1 (en) 1983-12-30 1983-12-30 Modified live pseudorabies viruses

Publications (3)

Publication Number Publication Date
DE3486160D1 DE3486160D1 (de) 1993-07-15
DE3486160T2 DE3486160T2 (de) 1993-11-25
DE3486160T3 true DE3486160T3 (de) 2002-11-21

Family

ID=24265400

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843486160 Expired - Fee Related DE3486160T3 (de) 1983-12-30 1984-11-07 Modifizierte lebende Pseudo-Rabies-Viren, diese enthaltende Impfstoffe gegen Pseudo-Rabies, Verfahren zur Herstellung und Verfahren zur Verwendung derselben.

Country Status (6)

Country Link
US (2) US4514497B1 (de)
EP (1) EP0149040B2 (de)
JP (1) JP2941804B2 (de)
AU (1) AU550147B2 (de)
CA (1) CA1242662A (de)
DE (1) DE3486160T3 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305323D0 (en) * 1983-02-25 1983-03-30 Baylor College Medicine Infectious bovine rhinotracheitis vaccine
NL8303501A (nl) * 1983-10-12 1985-05-01 Centraal Diergeneeskundig Inst Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat.
US5041536A (en) * 1984-05-02 1991-08-20 The Upjohn Company Pseudorabies virus (PRV) gene
US4738846A (en) * 1984-08-30 1988-04-19 The Salk Institute For Biological Studies Vaccine for vesicular stomatitis virus
US5128128A (en) * 1985-07-29 1992-07-07 The Upjohn Company Virus vaccine
AU591145B2 (en) * 1985-07-29 1989-11-30 Pharmacia & Upjohn Company Virus vaccine with deletion of an antigen of the wild-type virus
US5275934A (en) * 1985-07-29 1994-01-04 The Upjohn Company Method of detecting viral infection in vaccinated animals
US5834305A (en) * 1985-09-06 1998-11-10 Syntro Corporation Attenuated herpesvirus, herpesvirus which include foreign DNA encoding an amino acid sequence and vaccines containing same
US5068192A (en) * 1986-01-27 1991-11-26 Prutech Research And Development Partnership Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence
US4877737A (en) * 1985-09-06 1989-10-31 Prutech Research And Development Partnership Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same
US6121043A (en) * 1985-09-06 2000-09-19 Syntro Corporation Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome
US5763269A (en) * 1985-09-06 1998-06-09 Syntro Corporation Recombinant infectious bovine rhinotrocheitis virus
US5047237A (en) * 1985-09-06 1991-09-10 Prutech Research And Development Partnership Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine
US5352575A (en) * 1985-10-04 1994-10-04 The Upjohn Company Pseudorabies virus protein
US4703011A (en) 1985-11-12 1987-10-27 Novagene, Inc. Thymidine kinase deletion mutants of bovine herpesvirus-1
US6251634B1 (en) 1985-11-26 2001-06-26 Pharmacia & Upjohn Company Pseudorabies virus protein
US6261563B1 (en) * 1985-11-26 2001-07-17 Pharmacia & Upjohn Company Pseudorabies virus protein
WO1987004463A1 (en) * 1986-01-27 1987-07-30 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
US4711850A (en) * 1986-01-28 1987-12-08 Novagene, Inc. Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
US4753884A (en) * 1986-01-28 1988-06-28 Novagene, Inc. Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
US4999296A (en) * 1986-04-29 1991-03-12 Novagene, Inc. Thymidine kinase negative insertion mutants of pseudorabies virus and methods for the production of same
US4777239A (en) * 1986-07-10 1988-10-11 The Board Of Trustees Of The Leland Stanford Junior University Diagnostic peptides of human papilloma virus
US5037742A (en) * 1986-07-18 1991-08-06 E. I. Du Pont De Nemours And Company Pseudorabies virus recombinants and their use in the production of proteins
US5004693A (en) * 1986-07-18 1991-04-02 E. I. Du Pont De Nemours And Company Pseudorabies virus recombinants and their use in the production of proteins
ES2055687T3 (es) * 1986-10-08 1994-09-01 Upjohn Co Vacuna de virus.
AU628294B2 (en) * 1987-07-27 1992-09-17 Syntro Corporation Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
US5578468A (en) * 1987-08-10 1996-11-26 Duke University Site-specific RNA cleavage
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
AU2888089A (en) * 1988-01-26 1989-07-27 Baylor College Of Medicine Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same
US5069901A (en) * 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
US5871702A (en) * 1988-04-21 1999-02-16 Flexiclave, Inc. Methods and apparatus for sterilizing objects
US5039495A (en) * 1988-04-21 1991-08-13 Flexiclave, Inc. Apparatus for sterilizing articles such as dental handpieces
US5019359A (en) * 1988-04-21 1991-05-28 Flexiclave, Inc. Method and apparatus for rapid sterilization of material
JPH01275534A (ja) * 1988-04-27 1989-11-06 Zenkoku Nogyo Kyodo Kumiai Rengokai オーエスキー病ウイルス弱毒株
US5324664A (en) * 1988-08-08 1994-06-28 The Upjohn Company Herpes virus thymidien kinase-encoding DNA
FR2635267B1 (fr) * 1988-08-09 1992-05-22 Tokuyama Soda Kk Anticorps monoclonaux et procede pour les produire
US5132220A (en) * 1989-06-30 1992-07-21 The United States Of America As Represented By The Secretary Of Agriculture More virulent biotype isolated from wild-type virus
US4997932A (en) * 1989-11-13 1991-03-05 Boehringer Mannheim Corporation Method and kit for purifying nucleic acids
US5240703A (en) * 1991-03-01 1993-08-31 Syntro Corporation Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
US5498534A (en) * 1992-03-25 1996-03-12 The United States Of America As Represented By The Secretary Of Agriculture Method of removing color from wood pulp using xylanase from streptomyces roseiscleroticus NRRL B-11019
WO1993024147A1 (en) * 1992-05-29 1993-12-09 Smithkline Beecham Corporation Lecithin adjuvanted modified live virus vaccines
US5352596A (en) * 1992-09-11 1994-10-04 The United States Of America As Represented By The Secretary Of Agriculture Pseudorabies virus deletion mutants involving the EPO and LLT genes
WO1999003500A1 (en) * 1997-07-18 1999-01-28 Purdue Research Foundation Improved vaccines and method therefor
US20030224502A1 (en) * 1997-08-07 2003-12-04 Xenova Research Limited Recovery of virus from cell culture using a hypertonic salt solution
WO1999019466A2 (en) 1997-10-14 1999-04-22 Darwin Molecular Corporation Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
KR100689212B1 (ko) * 1999-01-29 2007-03-09 암겐 인코포레이티드 Ｇｃｓｆ 결합체
CN101831509A (zh) * 2010-05-31 2010-09-15 洛阳普莱柯生物工程有限公司 一种细胞蚀斑快速滴定狂犬病病毒的方法
CN104250640A (zh) * 2014-08-22 2014-12-31 普莱柯生物工程股份有限公司 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用
US20180030478A1 (en) 2016-07-01 2018-02-01 Research Development Foundation Elimination of proliferating cells from stem cell-derived grafts
CN108048413B (zh) * 2017-12-20 2021-06-25 哈药集团生物疫苗有限公司 伪狂犬病毒犬科动物分离株及其制备的灭活疫苗和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049794A (en) * 1974-06-24 1977-09-20 Bayer Aktiengesellschaft Treatment of infections in animals
AR216081A1 (es) * 1976-07-02 1979-11-30 Dso Pharmachim Un metodo de preparar un mutante virosico avirulento a partir del virus de aujeszky
NL8303501A (nl) * 1983-10-12 1985-05-01 Centraal Diergeneeskundig Inst Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat.

Also Published As

Publication number Publication date
EP0149040B1 (de) 1993-06-09
JPS60231620A (ja) 1985-11-18
DE3486160D1 (de) 1993-07-15
EP0149040A2 (de) 1985-07-24
DE3486160T2 (de) 1993-11-25
JP2941804B2 (ja) 1999-08-30
US4514497A (en) 1985-04-30
US4609548B1 (en) 1998-01-27
US4514497B1 (en) 1998-02-24
US4609548A (en) 1986-09-02
CA1242662A (en) 1988-10-04
AU3649884A (en) 1985-07-04
EP0149040B2 (de) 2002-05-22
EP0149040A3 (en) 1986-06-11
AU550147B2 (en) 1986-03-06

Similar Documents

Publication Publication Date Title
DE3486160T3 (de) Modifizierte lebende Pseudo-Rabies-Viren, diese enthaltende Impfstoffe gegen Pseudo-Rabies, Verfahren zur Herstellung und Verfahren zur Verwendung derselben.
DE69942659D1 (de) Verfahren zur Herstellung und Verwendung von durchsichtigen hitzebeständigen Harzen
DE3382722D1 (de) Mikroporöses blattförmiges Material, Verfahren zur Herstellung und damit hergestellte Gegenstände.
DE3484406D1 (de) Methode und apparat zur herstellung von anisotropen magneten.
DE3680130D1 (de) Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung.
ATE108067T1 (de) Impfstoff und verfahren zur herstellung.
DE69016521D1 (de) Verfahren zur Herstellung von Dialkylethern.
ATE17320T1 (de) Impfstoff, therapie gegen nicht-a nicht-b virale hepatitis und verfahren zur herstellung desselben.
ATE201593T1 (de) Verfahren zur inaktivierung eingehüllter viren
DE59101703D1 (de) Verfahren zur Herstellung von Dialkylcarbonaten.
DE3680632D1 (de) Verfahren zur herstellung von kohlenstoffasern und diese kohlenstoffasern.
DE59005420D1 (de) Verfahren zur Herstellung von Dialkylcarbonaten.
ATE16454T1 (de) Influenzavirus-vaccine, verfahren zu ihrer herstellung und verfahren zur vermehrung von influenzaviren.
ATE98643T1 (de) Aralkylaminalkoxyphenyl-derivate, verfahren zur herstellung und sie enthaltende zusammensetzungen.
DE69529648T2 (de) Verfahren zur Herstellung von cyclischen Organohydrogensiloxanen
DE3381989D1 (de) Bakteriophage und verfahren zur zuechtung.
ATE15369T1 (de) Verfahren zur herstellung von (thienyl-2)-2|thylaminen und(thienyl-3)-2-aethylaminen.
DE3482971D1 (de) Landwirtschaftliche zusammensetzungen, verfahren zur herstellung von landwirtschaftlichen zusammensetzungen und verfahren zur verwendung von landwirtschaftlichen zusammensetzungen.
DE59400935D1 (de) Verfahren zur Herstellung von Bezaldehyddialkylacetalen
AT358167B (de) Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
DE69507414D1 (de) Verfahren zur Herstellung von Octadienen
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.
ES550089A0 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
DE69217616D1 (de) Verfahren zur Herstellung von (S)-1-Phenyl-1,3-Propanediol und Derivaten
DE59006008D1 (de) Verfahren zur Herstellung von Dialkylcarbonaten.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee